Radiation Biology: Cell Survival Curves and Fractionation

Radiation biology (radiobiology) is the study of the effects of ionizing radiation on living systems. In radiation oncology, radiobiology provides the physiological and mathematical foundation for clinical treatment prescriptions. The goal of radiotherapy is to maximize tumor cell kill while preserving the regenerative capacity of surrounding normal tissues. This clinical index is achieved by dividing the total radiation dose into multiple small daily doses, a process known as fractionation.

This article outlines the biological mechanisms of radiation damage, the Linear-Quadratic cell survival model, the "4 Rs" of radiobiology, and the calculation of Biologically Effective Dose (BED).

---

1. Mechanisms of Radiation-Induced Cell Damage

Ionizing radiation kills cells primarily by damaging their DNA: * Direct Action: Radiation directly ionizes the atoms of the DNA molecule. This is the dominant mechanism for high linear energy transfer (high-LET) radiation, such as alpha particles or carbon ions. * Indirect Action: Radiation interacts with water molecules in the cell (water radiolysis), producing highly reactive free radicals (such as hydroxyl radicals, ·OH):

These free radicals diffuse a short distance and chemically attack the DNA. Indirect action is the dominant mechanism (70\%) for low-LET radiation, such as clinical megavoltage X-rays.

DNA Lesions Radiation produces single-strand breaks (SSBs) and double-strand breaks (DSBs) in the DNA double helix. SSBs are easily repaired by the cell's repair pathways. Unrepaired or misrepaired **double-strand breaks** are the primary lesions responsible for cell death.

---

2. The Linear-Quadratic (LQ) Model

The Linear-Quadratic (LQ) Model is the standard mathematical framework describing cell survival as a function of radiation dose. The fraction of cells surviving (S) a single dose (D) is:

Where: * \alpha (Linear component): Represents single-track lethal events (a single electron track producing a double-strand break). It is directly proportional to dose (D). * \beta (Quadratic component): Represents dual-track lethal events (two separate electron tracks producing sub-lethal lesions that interact to form a double-strand break). It is proportional to the square of the dose (D^2).

The $\alpha/\beta$ Ratio The ratio $\alpha/\beta$ (expressed in Gray) is the dose at which the linear and quadratic components of cell kill are equal: * **Early-Responding Tissues and Tumors (High $\alpha/\beta \approx 10\text{ Gy}$)**: Cell survival curve is relatively straight. These cells are less sensitive to changes in dose-per-fraction. Examples: most epithelial tumors, skin, gastrointestinal mucosa. * **Late-Responding Normal Tissues (Low $\alpha/\beta \approx 2\text{ to }4\text{ Gy}$)**: Cell survival curve has a prominent "shoulder" and is highly curved. These tissues are highly sensitive to the size of the dose-per-fraction. Sparing is maximized by using small fraction sizes. Examples: spinal cord, brain, kidneys.

---

3. The 4 Rs of Radiobiology

Fractionated radiotherapy relies on four biological processes that occur between dose fractions:

1. Repair: Normal cells repair sublethal DNA damage between fractions. Since late-responding tissues have lower \alpha/\beta ratios and greater repair capacity, separating doses by at least 6 hours spares normal tissues.
2. Reoxygenation: Hypoxic cells in a tumor are highly resistant to radiation because oxygen acts as a radiosensitizer (forming permanent oxygen-fixated DNA lesions). Fractionation kills aerobic cells on the outer layers, allowing oxygen to diffuse deeper into the remaining hypoxic core, sensitizing them for subsequent fractions.
3. Redistribution: Cells have varying radiosensitivity depending on their phase in the cell cycle. Cells are most sensitive in G2 and M phases, and most resistant in S phase. Fractionation allows surviving resistant cells to progress (redistribute) into sensitive phases before the next dose.
4. Repopulation: Surviving cells (both tumor and normal) divide between fractions. While normal tissue repopulation is desirable, tumor repopulation (clonogenic accelerated repopulation) is a major cause of treatment failure if the overall treatment time is extended.

---

4. Biologically Effective Dose (BED) Calculations

To compare different clinical fractionation schedules (e.g., comparing a conventional plan of 2 Gy \times 30 fractions with a hypofractionated plan of 4 Gy \times 10 fractions), physicists calculate the Biologically Effective Dose (BED):

Where: * N: The number of fractions. * d: The dose per fraction (so N · d is the total physical dose). * \alpha/\beta: The tissue-specific radiobiology parameter (typically 10 Gy for tumor, 3 Gy for late-responding normal tissue).

Clinical Sample Calculation: A clinic wants to change a prostate treatment from $2.0\text{ Gy} \times 37\text{ fractions} = 74\text{ Gy}$ to a hypofractionated schedule delivering $3.0\text{ Gy}$ fractions. What is the equivalent total dose ($N \cdot d$) to maintain the same late-tissue toxicity (assuming $\alpha/\beta = 3\text{ Gy}$)?

#### Step 1: Calculate BED of the Reference Schedule

#### Step 2: Solve for the New Fraction Number (N_{new}) at 3.0 Gy/fraction

Rounding to 20 fractions, the total physical dose is 20 \times 3.0 Gy = 60 Gy. This hypofractionated schedule delivers the equivalent late tissue effect in 4 weeks instead of 7.4 weeks.

---

Conclusion

Radiobiology provides the essential clinical justification for radiotherapy scheduling. By applying the Linear-Quadratic survival model and utilizing equations like the Biologically Effective Dose (BED), medical physicists customize treatments. This mathematical tuning ensures that conventional fractionation, hypofractionated SBRT, or hyperfractionated schemes maximize tumor destruction while preserving the integrity of critical normal tissues.